Advances in engineered bacteria vaccines for enhancing anti-cancer immunity

被引:1
|
作者
Liu, Wu [1 ]
Chen, Wenjing [2 ]
Cai, Yujie [2 ]
Tang, Yanhua [3 ]
Chen, Tingtao [1 ,4 ,5 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Jiangxi Med Coll, Nanchang 330008, Jiangxi, Peoples R China
[2] Nanchang Univ, Jiangxi Med Coll, Sch Pharm, Nanchang 330008, Jiangxi, Peoples R China
[3] Nanchang Univ, Affiliated Hosp 2, Jiangxi Med Coll, Dept Cardiovasc Surg, 1 Minde Rd, Nanchang 330008, Jiangxi, Peoples R China
[4] Nanchang Univ, Jiangxi Med Coll, MOE Basic Res & Innovat Ctr Targeted Therapeut Sol, Sch Pharm,Jiangxi Prov Key Lab Bioengn Drugs, Nanchang 330031, Jiangxi, Peoples R China
[5] Nanchang Univ, Inst Translat Med, Jiangxi Med Coll, Natl Engn Res Ctr Bioengn Drugs & Technol, 1299 Xuefu Ave, Nanchang 330031, Jiangxi, Peoples R China
来源
MICROBIOME RESEARCH REPORTS | 2025年 / 4卷 / 01期
关键词
Engineered bacteria; antitumor; neoantigenic; immunotherapy;
D O I
10.20517/mrr.2024.75
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Advances in synthetic biology have enabled the development of tumor-targeted live bacterial therapeutics. In a recent study published in Nature, Redenti et al. engineered Escherichia coli Nissle 1917(EcNc Delta lon/Delta ompT/LLO+ nAg), which exploits the advantages of living medicines to deliver arrays of tumor-specific neoantigenic epitope in optimal environments, thereby providing a novel strategy for developing effective and durable cancer immunotherapies.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Near-infrared photoimmunotherapy and anti-cancer immunity
    Nakajima, Kohei
    Ogawa, Mikako
    INTERNATIONAL IMMUNOLOGY, 2024, 36 (02) : 57 - 64
  • [42] Lymphatic system regulation of anti-cancer immunity and metastasis
    Lei, Pin-Ji
    Fraser, Cameron
    Jones, Dennis
    Ubellacker, Jessalyn M.
    Padera, Timothy P.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [43] Does patient age influence anti-cancer immunity?
    Pawelec, Graham
    SEMINARS IN IMMUNOPATHOLOGY, 2019, 41 (01) : 125 - 131
  • [44] Endothelial autophagy blockade fosters anti-cancer immunity
    Villari, Giulia
    Serini, Guido
    EMBO MOLECULAR MEDICINE, 2024, 16 (01) : 1 - 3
  • [45] Editorial: Immunity in the development of anti-cancer drug resistance
    Meng, Ya
    Wang, Haitao
    Li, Xuebing
    Wu, Xinwei
    Sun, Heng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [46] Training the host organism to enhance anti-cancer immunity
    Ferrer, Miriam
    Janowitz, Tobias
    CANCER CELL, 2022, 40 (07) : 703 - 705
  • [47] Does patient age influence anti-cancer immunity?
    Graham Pawelec
    Seminars in Immunopathology, 2019, 41 : 125 - 131
  • [48] Tricking the balance: NK cells in anti-cancer immunity
    Pahl, Jens
    Cerwenka, Adelheid
    IMMUNOBIOLOGY, 2017, 222 (01) : 11 - 20
  • [49] The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
    Urban-Wojciuk, Zuzanna
    Khan, Mohd M.
    Oyler, Benjamin L.
    Fahraeus, Robin
    Marek-Trzonkowska, Natalia
    Nita-Lazar, Aleksandra
    Hupp, Ted R.
    Goodlett, David R.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [50] Carbon Ion Irradiation Activates Anti-Cancer Immunity
    Sudo, Makoto
    Tsutsui, Hiroko
    Fujimoto, Jiro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (05)